DragonWave Inc. (TSE:DWI), a Canadian tech stock, climbed after announcing a Sprint equipment deal
Sean Mason | October 20, 2016 | SmallCapPower
A Canadian tech stock raced higher after an agreement with Sprint. Here’s some small stocks making big moves on Thursday, October 20, 2016 (as of 4 pm EST):
Canadian tech stock DragonWave Inc. (TSE:DWI) surged 91% to $5.65 on Thursday after the supplier of packet microwave radio systems for next-generation IP networks announced that Sprint has selected its microwave backhaul equipment for network deployment as part of the company’s densification and optimization strategy.
As well, shares of Quest PharmaTech Inc. (CVE:QPT) jumped 90% to $0.095 as the biopharmaceutical company said its subsidiary, OncoQuest Inc., has released “positive” results from its pre-clinical pharmacology studies using its Anti-MUC1 antibody, MAb AR20.5, against pancreatic cancer in a human MUC1 expressing transgenic mouse model.
Leading Edge Materials Corp. (CVE:LEM), meanwhile, reported the discovery of its first lithium project, Bergby, located in central Sweden. Analytical results for the first 27 boulder samples have been received, and average 0.85% Li2O (lithium oxide) and range from 0.08% Li2O to 2.3% Li2O. Leading Edge Materials stock moved up 30% to $0.45 following the announcement.
Finally, Theralase Technologies Inc. (CVE:TLT) shares climbed 13% to $0.40 after the biotech company announced that Health Canada has granted it Investigational Testing Authorization approval to use its patent pending TLC-3200 Photo Dynamic Therapy Laser System and TLC-3400 Dosimetry Fibre Optic Cage to begin a Phase Ib clinical trial for the treatment of Non-Muscle Invasive Bladder Cancer.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
DISCLAIMER
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
